Pulse Medical (PLSE): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
Risks for Pulse Biosciences, Inc. (PLSE) are tied to the commercialization pace of Nano-Pulse systems and liquidity costs. This EV/EBITDA chart, provided by GURU.Markets, demonstrates these fluctuations, where the 0.00 level captures the latest values. Stability is supported by outsourced manufacturing and cloud data storage, while high barriers to entry are guaranteed by unique patents for nanosecond pulses.
פילוחי מדדים מקיפים ואנליטיקה עבור pulsebiosciences.com (PLSE)
To assess the credit quality of Pulse Biosciences, Inc. (PLSE), the analyst utilizes an EV/EBITDA multiple chart, which relates the total enterprise value to operating profit before depreciation and amortization. Given the costs associated with specialized logistics for high-precision equipment, this indicator strips the valuation of debt burdens and tax distortions, allowing the investor to determine a fair premium for the scalability of bioelectric systems.
